|
Andrew Dunn
@
AndrewE_Dunn
Washington, DC
|
|
Pharma and biotech reporter for @businessinsider Say hello: adunn@businessinsider.com
|
|
|
2.932
Tweetovi
|
998
Pratim
|
2.416
Osobe koje vas prate
|
| Tweetovi |
|
Andrew Dunn
@AndrewE_Dunn
|
14 h |
|
Worth a read if you missed it earlier today: @damiangarde has a great explanation of Regeneron's coronavirus R&D plan statnews.com/2020/02/05/in-…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
18 h |
|
Vaccine efforts against #nCoV19 will likely take years, with history as a guide. The hope with testing some antivirals already on market is that timeline could be much quicker in getting patients a treatment: businessinsider.com/wuhan-coronavi…
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Lydia Ramsey
@lydiaramsey125
|
18 h |
|
Fun one up this morning: I spoke to @ServierPharma CEO about the three "R's" he's used to guide his career. businessinsider.com/servier-pharma…
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Meg Tirrell
@megtirrell
|
19 h |
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
19 h |
|
A milestone in cancer and cloud genomics.
“The broad availability and quality of the new data set will almost certainly spur a wave of biological insights.” write U-Mich. researchers Marcin Cieslik and Arul Chinnaiyan in a commentary piece here: nature.com/articles/d4158…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
19 h |
|
Nature's main link isn't live yet, but here's an editorial describing the effort that is up: nature.com/articles/d4158…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
19 h |
|
Nature just published 20+ papers based off one of the largest collaborative efforts in cancer research: 1,300+ scientists sequencing 2,658 whole genomes from 37 countries in 38 different tumor types.
Full collection of Nature papers, out now: nature.com/collections/pc…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
21 h |
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
5. velj |
|
Going into #SOTU, here’s what Capital Alpha healthcare analysts wrote on if Trump makes no reference to the IPI model (he didn’t):
“If Trump doesn’t make any decisive comments on the model, we’d question whether he has a viable plan for acting on it.”
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Adam Feuerstein
@adamfeuerstein
|
4. velj |
|
$GILD on call: No knowledge of additional #coronavirus responses to remdesivir.
Waiting for clinical data.
On manufacturing capacity: “We are investing heavily to be prepared as best we can.”
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
4. velj |
|
To say the least, this has been a fast-moving space.
J&J, Regeneron, Gilead and others have all disclosed R&D plans for curing or treating the novel coronavirus. Here's the latest round-up on all their efforts: businessinsider.com/wuhan-coronavi…
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Zachary Tracer
@ZTracer
|
4. velj |
|
real nice overview from @AndrewE_Dunn on how big pharma is gearing up to fight the Wuhan coronavirus: businessinsider.com/wuhan-coronavi…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
4. velj |
|
George Yancopoulos on coronavirus R&D efforts:
"The life-saving results seen with our investigational Ebola therapy last year underscore the potential impact of Regeneron's rapid response platform for addressing emerging outbreaks."
$REGN PR here: investor.regeneron.com/news-releases/…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
4. velj |
|
a16z's growth in biotech/healthcare investing:
2015: $200m fund + hire Vijay Ponde
2017: $450m fund + add @JorgeCondeBio
2019: Add Julie Yoo as GP
2020: $750m fund + add @vintweeta
Here's what the Bio Fund 3 team is targeting: businessinsider.com/andreessen-hor…
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
CNBC
@CNBC
|
3. velj |
|
Coronavirus testing needs to be more widespread, former FDA Commissioner Dr. Scott Gottlieb says. “We have to assume it’s already here and circulating.” cnb.cx/392v4Hc pic.twitter.com/8KHrhsaDnF
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
31. sij |
|
Simple — yet stunning — graphic to see.
# of confirmed cases of coronavirus in China, per daily situation reports from WHO. Just under 25,000 cases if you add suspected cases in China. pic.twitter.com/yHLc9NwMZ0
|
||
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Lydia Ramsey
@lydiaramsey125
|
31. sij |
|
This week's Dispensed is out!
In it:
- So much on $ONEM + the primary care biz overall
- @AndrewE_Dunn 's insights from biotech/pharma earnings
- my deep-dive on $WBA's partnership strategy
Subscribe!
businessinsider.com/dispensed-week…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
31. sij |
|
Just published in The Lancet: a new model by U. of Hong Kong researchers says 75,800 individuals in Wuhan may have been infected w/ coronavirus as of Jan. 25.
Also says multiple major Chinese cities may have enough cases for local epidemics. thelancet.com/pb-assets/Lanc…
|
||
|
|
||
|
Andrew Dunn
@AndrewE_Dunn
|
31. sij |
|
|
||
| Andrew Dunn proslijedio/la je tweet | ||
|
Lydia Ramsey
@lydiaramsey125
|
31. sij |
|
Here we go: One Medical is set to start trading today after raising $245 million in its IPO businessinsider.com/one-medical-go…
|
||
|
|
||